Metuchen, NJ, United States of America

Rositza Iordanova Petrova

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Intervet Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rositza Iordanova Petrova. Retrieved from https://idiyas.com/inventor/rositza-iordanova-petrova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rositza Iordanova Petrova: Innovator in Pharmaceutical Chemistry

Introduction

Rositza Iordanova Petrova is a notable inventor based in Metuchen, NJ (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target JAK-mediated diseases.

Latest Patents

Rositza holds a patent for her work on crystalline forms of 1-[(3R,4S)-4-cyanotetrahydropyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridyl)amino]pyrazole-4-carboxamide. This patent is particularly relevant as it relates to processes for the preparation of these crystalline forms. The compound is recognized for its potential utility in treating conditions such as atopic dermatitis.

Career Highlights

Rositza is currently employed at Intervet Inc., where she continues to innovate and contribute to the pharmaceutical industry. Her work is characterized by a commitment to advancing medical treatments through her research and development efforts.

Collaborations

Some of her notable coworkers include Christophe Pierre Alain Chassaing and Xiaoling Jin, with whom she collaborates on various projects within the company.

Conclusion

Rositza Iordanova Petrova exemplifies the spirit of innovation in the pharmaceutical field, with her patent reflecting her dedication to improving healthcare solutions. Her contributions are paving the way for advancements in the treatment of significant medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…